Literature DB >> 12057837

Mouse model of optic neuropathy caused by mitochondrial complex I dysfunction.

Xian Zhang1, Dirk Jones, F Gonzalez-Lima.   

Abstract

We developed a mouse model of optic neuropathy caused by mitochondrial complex I dysfunction by intravitreal administration of rotenone, a complex I inhibitor, in CBA/J mice. Retinal thickness was measured in sections stained histochemically for complex I enzymatic activity. The retinal ganglion cell layer of eyes injected with rotenone was significantly thinner than that of the control eyes injected with the vehicle dimethyl sulfoxide at 1, 24, and 48-h survival time groups. The largest reduction was 43% at 24-h post-injection. This effect is consistent with the degeneration of retinal ganglion cells in Leber's hereditary optic neuropathy. This is the first animal model of optic neuropathy caused by mitochondrial dysfunction, and it could be used as a quick and convenient way to test new treatments for mitochondrial neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12057837     DOI: 10.1016/s0304-3940(02)00327-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  26 in total

1.  Transcellular degradation of axonal mitochondria.

Authors:  Chung-ha O Davis; Keun-Young Kim; Eric A Bushong; Elizabeth A Mills; Daniela Boassa; Tiffany Shih; Mira Kinebuchi; Sebastien Phan; Yi Zhou; Nathan A Bihlmeyer; Judy V Nguyen; Yunju Jin; Mark H Ellisman; Nicholas Marsh-Armstrong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

Review 2.  Mitochondrial optic neuropathy: In vivo model of neurodegeneration and neuroprotective strategies.

Authors:  Julio C Rojas; Francisco Gonzalez-Lima
Journal:  Eye Brain       Date:  2010-03-10

Review 3.  Mitochondrial disorders and the eye.

Authors:  Nicole J Van Bergen; Rahul Chakrabarti; Evelyn C O'Neill; Jonathan G Crowston; Ian A Trounce
Journal:  Eye Brain       Date:  2011-09-26

4.  Neuroprotective effects of near-infrared light in an in vivo model of mitochondrial optic neuropathy.

Authors:  Julio C Rojas; Jung Lee; Joseph M John; F Gonzalez-Lima
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

Review 5.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

6.  Long-term evaluation of Leber's hereditary optic neuropathy-like symptoms in rotenone administered rats.

Authors:  Li Zhang; Laura Liu; Ann L Philip; Juan C Martinez; Juan C Guttierez; Mathieu Marella; Gaurav Patki; Akemi Matsuno-Yagi; Takao Yagi; Biju B Thomas
Journal:  Neurosci Lett       Date:  2014-12-03       Impact factor: 3.046

7.  Successful amelioration of mitochondrial optic neuropathy using the yeast NDI1 gene in a rat animal model.

Authors:  Mathieu Marella; Byoung Boo Seo; Biju B Thomas; Akemi Matsuno-Yagi; Takao Yagi
Journal:  PLoS One       Date:  2010-07-08       Impact factor: 3.240

8.  Dimethyl sulphoxide dose-response on rat retinal function.

Authors:  Tina I Tsai; Bang V Bui; Algis J Vingrys
Journal:  Doc Ophthalmol       Date:  2009-09-11       Impact factor: 2.379

9.  Methylene blue provides behavioral and metabolic neuroprotection against optic neuropathy.

Authors:  Julio C Rojas; Joseph M John; Jung Lee; F Gonzalez-Lima
Journal:  Neurotox Res       Date:  2009-02-24       Impact factor: 3.911

10.  Neuroprotective effects of memantine in a mouse model of retinal degeneration induced by rotenone.

Authors:  Julio C Rojas; Jose A Saavedra; F Gonzalez-Lima
Journal:  Brain Res       Date:  2008-04-12       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.